Historical Valuation
RXO Inc (RXO) is now in the Overvalued zone, suggesting that its current forward PE ratio of 414.19 is considered Overvalued compared with the five-year average of 85.45. The fair price of RXO Inc (RXO) is between 0.98 to 5.77 according to relative valuation methord. Compared to the current price of 14.59 USD , RXO Inc is Overvalued By 152.97%.
Relative Value
Fair Zone
0.98-5.77
Current Price：14.59
152.97%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
RXO Inc (RXO) has a current Price-to-Book (P/B) ratio of 1.33. Compared to its 3-year average P/B ratio of 3.37 , the current P/B ratio is approximately -60.42% higher. Relative to its 5-year average P/B ratio of 3.28, the current P/B ratio is about -59.34% higher. RXO Inc (RXO) has a Forward Free Cash Flow (FCF) yield of approximately -0.85%. Compared to its 3-year average FCF yield of 1.74%, the current FCF yield is approximately -149.03% lower. Relative to its 5-year average FCF yield of 2.34% , the current FCF yield is about -136.54% lower.
P/B
Median3y
3.37
Median5y
3.28
FCF Yield
Median3y
1.74
Median5y
2.34
Competitors Valuation Multiple
AI Analysis for RXO
The average P/S ratio for RXO competitors is 3.58, providing a benchmark for relative valuation. RXO Inc Corp (RXO.N) exhibits a P/S ratio of 0.36, which is -89.89% above the industry average. Given its robust revenue growth of 36.63%, this premium appears sustainable.
Performance Decomposition
AI Analysis for RXO
1Y
3Y
5Y
Market capitalization of RXO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of RXO in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is RXO currently overvalued or undervalued?
RXO Inc (RXO) is now in the Overvalued zone, suggesting that its current forward PE ratio of 414.19 is considered Overvalued compared with the five-year average of 85.45. The fair price of RXO Inc (RXO) is between 0.98 to 5.77 according to relative valuation methord. Compared to the current price of 14.59 USD , RXO Inc is Overvalued By 152.97% .
What is RXO Inc (RXO) fair value?
RXO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of RXO Inc (RXO) is between 0.98 to 5.77 according to relative valuation methord.
How does RXO's valuation metrics compare to the industry average?
The average P/S ratio for RXO's competitors is 3.58, providing a benchmark for relative valuation. RXO Inc Corp (RXO) exhibits a P/S ratio of 0.36, which is -89.89% above the industry average. Given its robust revenue growth of 36.63%, this premium appears sustainable.
What is the current P/B ratio for RXO Inc (RXO) as of Jan 10 2026?
As of Jan 10 2026, RXO Inc (RXO) has a P/B ratio of 1.33. This indicates that the market values RXO at 1.33 times its book value.
What is the current FCF Yield for RXO Inc (RXO) as of Jan 10 2026?
As of Jan 10 2026, RXO Inc (RXO) has a FCF Yield of -0.85%. This means that for every dollar of RXO Inc’s market capitalization, the company generates -0.85 cents in free cash flow.
What is the current Forward P/E ratio for RXO Inc (RXO) as of Jan 10 2026?
As of Jan 10 2026, RXO Inc (RXO) has a Forward P/E ratio of 414.19. This means the market is willing to pay $414.19 for every dollar of RXO Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for RXO Inc (RXO) as of Jan 10 2026?
As of Jan 10 2026, RXO Inc (RXO) has a Forward P/S ratio of 0.36. This means the market is valuing RXO at $0.36 for every dollar of expected revenue over the next 12 months.